Molecular size-dependent specificity of hyaluronan on functional properties, morphology and matrix composition of mammary cancer cells.
Ontology highlight
ABSTRACT: High levels of hyaluronan (??), a major extracellular matrix (ECM) glycosaminoglycan, have been correlated with poor clinical outcome in several malignancies, including breast cancer. The high and low molecular weight H? forms exert diverse biological functions. Depending on their molecular size, ?? forms either promote or attenuate signaling cascades that regulate cancer progression. In order to evaluate the effects of different ?? forms on breast cancer cells' behavior, ?? fragments of defined molecular size were synthesized. Breast cancer cells of different estrogen receptor (ER) status - the low metastatic, ER?-positive MCF-7 epithelial cells and the highly aggressive, ER?-positive MDA-MB-231 mesenchymal cells - were evaluated following treatment with HA fragments. Scanning electron microscopy revealed that HA fragments critically affect the morphology of breast cancer cells in a molecular-size dependent mode. Moreover, the ?? fragments affect cell functional properties, the expression of major ECM mediators and epithelial-to-mesenchymal transition (???) markers. Notably, treatment with 200?kDa ?? increased the expression levels of the epithelial marker ?-cadherin and reduced the expression levels of HA synthase 2 and mesenchymal markers, like fibronectin and snail2/slug. These novel data suggest that the effects of HA in breast cancer cells depend on the molecular size and the ER status. An in-depth understanding on the mechanistic basis of these effects may contribute on the development of novel therapeutic strategies for the pharmacological targeting of aggressive breast cancer.
SUBMITTER: Tavianatou AG
PROVIDER: S-EPMC7852304 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA